The Association of HFSA Optimal Medical Therapy Certification Completion With Sodium Glucose Cotransporter-2 Inhibitor Prescribing - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Relationship Between Completion of HFSA Optimal Medical Therapy Certification and the Prescription of Sodium-Glucose Cotransporter-2 Inhibitors

  • By

  • Brittany Chapman

  • Harsh Patolia

  • Delaney Ryan

  • Alex Milinovich

  • Eva Steinel

  • Chris Babiuch

  • Jerry D. Estep

  • Richard Rothman

  • Amanda R. Vest

  • Nancy M. Albert

  • Lars G. Svensson

  • Samir Kapadia

  • Randall C. Starling

  • Trejeeve Martyn

  • July 15, 2026

Share

  • 1

    SGLT2 inhibitors are a core component of guideline-directed heart failure therapy, but their use remains low in routine ambulatory practice.

  • 2

    HFSA OMT-Cert is a brief asynchronous educational program covering guideline-directed therapy indications, dosing, contraindications, monitoring, and adverse effects.

  • 3

    Previous survey evidence associated OMT-Cert completion with greater clinician-reported comfort initiating and optimizing guideline-directed therapy, including SGLT2 inhibitors.

  • 4

    New SGLT2i prescribing increased from 5.9% of eligible encounters before certification to 9.6% afterward; the adjusted association was modest and of borderline statistical significance.

  • 5

    In an exploratory analysis, postcertification encounters with LVEF ≤40% had greater odds of a new SGLT2i prescription, but this finding was hypothesis-generating.

Original Source(s)

Related Content